# Long-term efficacy and safety of omeprazole in patients with Zollinger-Ellison syndrome: A prospective study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/long-term-efficacy-and-safety-of-omeprazole-in-patients-with-zollinger-ellison/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Paul N. Maton,Rakesh Vinayek,Harold Frucht,K.A. McArthur,Larry S. Miller,Z. A. Saeed,Jerry D. Gardner,Robert T. Jensen |
| Citations | 150 |
| DOI | 10.1016/0016-5085(89)91485-6 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine,Pharmacology, Toxicology and Pharmaceutics |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W1497912223 |
| PMID | 2777040 |
| Type | article |
| Year | 1989 |

## Paper authors

- [Rakesh Vinayek](https://scholariq.org/researchers/rakesh-vinayek/)

## Paper journal

- [Gastroenterology](https://scholariq.org/journals/gastroenterology/)

## Paper primary topic

- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)

## Paper topics

- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)
- [Pharmacogenetics and Drug Metabolism](https://scholariq.org/topics/pharmacogenetics-and-drug-metabolism/)
- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.